Camurus AB (CAMX.ST)
CAMX.ST on Stockholm Stock Exchange
113.80SEK
20 Apr 2018
113.80SEK
20 Apr 2018
Change (% chg)
-0.20kr (-0.18%)
-0.20kr (-0.18%)
Prev Close
114.00kr
114.00kr
Open
115.00kr
115.00kr
Day's High
115.00kr
115.00kr
Day's Low
113.40kr
113.40kr
Volume
41,434
41,434
Avg. Vol
39,994
39,994
52-wk High
147.80kr
147.80kr
52-wk Low
91.30kr
91.30kr
About
Camurus AB is a Sweden-based research and development based pharmaceutical company with a focus on the development and commercialization of specialty medicines, providing patients suffering from serious and chronic disease, such as opioid dependence, pain, cancer, acromegaly, and neuroendocrine tumors. The Company has a... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | kr4,242.63 |
| Shares Outstanding(Mil.): | 37.28 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CAMX.ST | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 31.01 | 33.60 |
| EPS (TTM): | -5.11 | -- | -- |
| ROI: | -40.15 | 13.60 | 13.19 |
| ROE: | -40.15 | 15.26 | 15.00 |
BRIEF-Camurus Q4 Operating Loss Widens To SEK 66.1 Million
* Q4 NET SALES SEK 5.5 MILLION VERSUS SEK 37.1 MILLION YEAR AGO
BRIEF-Camurus AB Q4 Net Revenue Sek 5.5 Million Versus Sek 37.1 Million Year Ago
* Q4 NET REVENUE SEK 5.5 MILLION VERSUS SEK 37.1 MILLION YEAR AGO
BRIEF-Camurus Q3 operating loss widens to SEK 67.1 million
* Q3 NET REVENUE SEK 12.5 MILLION VERSUS SEK 30.5 MILLION YEAR AGO
Estimates